- Home
- AXSM vs LAD Comparison
AXSM vs LAD Comparison
Compare AXSM & LAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | LAD |
|---|---|---|
| Founded | 2012 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 8.2B |
| IPO Year | 2015 | 1996 |
Fundamental Metrics
Financial Performance| Metric | AXSM | LAD |
|---|---|---|
| Price | $184.87 | $326.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 21 | 12 |
| Target Price | $189.57 | ★ $387.83 |
| AVG Volume (30 Days) | ★ 806.9K | 217.6K |
| Earning Date | 02-17-2026 | 02-11-2026 |
| Dividend Yield | N/A | ★ 0.66% |
| EPS Growth | N/A | ★ 18.36 |
| EPS | N/A | ★ 34.59 |
| Revenue | $561,263,000.00 | ★ $37,610,600,000.00 |
| Revenue This Year | $67.10 | $5.55 |
| Revenue Next Year | $58.73 | $4.46 |
| P/E Ratio | ★ N/A | $9.60 |
| Revenue Growth | ★ 65.83 | 8.42 |
| 52 Week Low | $86.99 | $262.10 |
| 52 Week High | $184.40 | $405.14 |
Technical Indicators
Market Signals| Indicator | AXSM | LAD |
|---|---|---|
| Relative Strength Index (RSI) | 68.77 | 44.22 |
| Support Level | $172.05 | $326.99 |
| Resistance Level | $179.00 | $337.69 |
| Average True Range (ATR) | 8.01 | 8.00 |
| MACD | 0.72 | -1.42 |
| Stochastic Oscillator | 94.81 | 20.07 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About LAD Lithia Motors Inc.
Lithia Motors is a retailer of new and used vehicles and related services. The company offers over 50 brands of vehicles at nearly 500 stores globally across the US, Canada, and UK. The company has expanded largely through the acquisition of dealerships in smaller regional markets but now seeks to grow in any part of the US and we expect more deals over time in the US and, at times, abroad. Annual revenue in 2024 was $36.2 billion and we see over $50 billion possible in a few years. The US was 78% of 2024 revenue and the UK second at 19%, due to the 2024 Pendragon acquisition. In 2024, new vehicle sales were about 49% of total revenue. Lithia was founded in 1946, went public in 1996, and is the largest US auto dealer. It is based in Medford, Oregon.